Výsledky vyhledávání - "M. J. Madrigal Domínguez"

AB1315 SARILUMAB IN PATIENTS WITH REFRACTORY GRAVES’ ORBITOPATHY. EFFECTIVENESS AND SAFETY IN A SERIES OF CASES IN CLINICAL PRACTICE

Autor: V. Moreira Navarrete, F. J. Toyos Sáenz de Miera, A. M. Garrido Hermosilla, P. Muñoz Reinoso, M. J. Madrigal Domínguez, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 81:1764.2-1765

BackgroundGraves’ orbitopathy (GO) is an autoimmune disease of the retroocular tissues that occurs in patients with Graves’ disease. Tocilizumab (TCZ), an interleukin (IL)-6 inhibitor has been used in patients with glucocorticoid (GC)-resistant G

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d4fc04fdbcc1786adaf24ee371386555
https://doi.org/10.1136/annrheumdis-2022-eular.4039

Zobrazit plný text záznamu

AB1027 EFFECTIVENESS OF SUBCUTANEOUS ANTI-INTERLEUCINE 6 TREATMENT IN PATIENTS WITH ACTIVE MODERATE-SEVERE GRAVES’ ORBITOPATHY REFRACTORY TO CONVENTIONAL THERAPY

Autor: M. J. Madrigal Domínguez, M. Gessa Sorroche, Dolores Ruiz-Montesinos, L. Fernández de la Fuente Bursón, J. J. Pérez Venegas, F. J. Toyos Sáenz de Miera, M. C. Díaz Ruiz

Publikováno v: Annals of the Rheumatic Diseases. 79:1806.2-1806

Background:Graves’ Orbitopathy (OG) is the main extrathyroid manifestation of Graves’ disease (GD). Up to 25% of patients have moderate-severe inflammatory activity with a risk of major sequelae. Intravenous (i.v.) glucocorticoids (GC) pulses are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90e6178124f293b45d627834840b18c5
https://doi.org/10.1136/annrheumdis-2020-eular.6201

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání